These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 32008791)
1. Trends in the surgical management of malignant ovarian germcell tumors. Nasioudis D; Mastroyannis SA; Latif NA; Ko EM Gynecol Oncol; 2020 Apr; 157(1):89-93. PubMed ID: 32008791 [TBL] [Abstract][Full Text] [Related]
2. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors. Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535 [TBL] [Abstract][Full Text] [Related]
3. The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors. Qin B; Xu W; Li Y Jpn J Clin Oncol; 2020 Mar; 50(3):282-287. PubMed ID: 31867612 [TBL] [Abstract][Full Text] [Related]
4. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Kumar S; Shah JP; Bryant CS; Imudia AN; Cote ML; Ali-Fehmi R; Malone JM; Morris RT Gynecol Oncol; 2008 Aug; 110(2):125-32. PubMed ID: 18571705 [TBL] [Abstract][Full Text] [Related]
6. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors. Wang J; Chen R; Li J; Lu X Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors. Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K Int J Gynecol Cancer; 2019 Mar; 29(3):554-559. PubMed ID: 30700566 [TBL] [Abstract][Full Text] [Related]
9. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network. Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Lymphadenectomy in Different Stages of Malignant Germ Cell Tumor of the Ovary Based on Propensity Score Matching. Chen Y; Ning Y; Zhang Q; Xie Y Comb Chem High Throughput Screen; 2018; 21(9):652-661. PubMed ID: 30569854 [TBL] [Abstract][Full Text] [Related]
11. Malignant Mixed Germ Cell Tumors of the Ovary: An Analysis of 100 Cases Emphasizing the Frequency and Interrelationships of Their Tumor Types. Safdar NS; Stall JN; Young RH Am J Surg Pathol; 2021 Jun; 45(6):727-741. PubMed ID: 33284192 [TBL] [Abstract][Full Text] [Related]
12. Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapy. Nasioudis D; Ko EM; Haggerty AF; Cory L; Giuntoli RL; Burger RA; Morgan MA; Latif NA Gynecol Oncol; 2020 Jun; 157(3):613-618. PubMed ID: 32359845 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors. Nasioudis D; Kanninen TT; Holcomb K; Sisti G; Witkin SS Gynecol Oncol; 2017 May; 145(2):243-247. PubMed ID: 28292524 [TBL] [Abstract][Full Text] [Related]
14. Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence. Topuz S; Iyibozkurt AC; Akhan SE; Keskin N; Yavuz E; Salihoglu Y; Bengisu E; Berkman S Eur J Gynaecol Oncol; 2008; 29(6):635-7. PubMed ID: 19115694 [TBL] [Abstract][Full Text] [Related]
15. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases. Xu W; Li Y Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571 [TBL] [Abstract][Full Text] [Related]
16. Malignant ovarian germ cell tumor - role of surgical staging and gonadal dysgenesis. Lin KY; Bryant S; Miller DS; Kehoe SM; Richardson DL; Lea JS Gynecol Oncol; 2014 Jul; 134(1):84-9. PubMed ID: 24836278 [TBL] [Abstract][Full Text] [Related]
17. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database. Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136 [TBL] [Abstract][Full Text] [Related]
18. Role of optimal cytoreduction in patients with dysgerminoma. Bandala-Jacques A; Estrada-Rivera F; Cantu D; Prada D; Montalvo-Esquivel G; González-Enciso A; Barquet-Munoz SA Int J Gynecol Cancer; 2019 Nov; 29(9):1405-1410. PubMed ID: 31594835 [TBL] [Abstract][Full Text] [Related]
19. Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base. Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Holcomb K Gynecol Oncol; 2017 Nov; 147(2):296-301. PubMed ID: 28803748 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors. Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]